Skip to main content

Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know

Rheumatology International volume 38, pages 1163–1168 (2018)Cite this article

Abstract

Patients with systemic rheumatic diseases (SRDs) may require admission to the intensive care unit (ICU) throughout the course of their disease. Therefore, the rheumatologist needs an understanding of the factors which may influence the course of patients with SRDs who are admitted to ICU. These include the causes for admission, patient characteristics including comorbidities and drug therapies, outcome (in-ICU mortality and causes of death), and prognostic factors. Infections and exacerbation/complications of SRDs are the most common (and potentially reversible) reasons for both admission and death on ICU. Mortality in patients with SRDs admitted to ICU has been reported to be either no different or higher than ‘general’ ICU patients. Reported prognostic factors included patient and disease characteristics, as well as ICU factors, including scoring systems. Rheumatologists need to be aware of the factors surrounding admission of patients with SRDs to ICU, including the need for strong links with critical care medicine.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F et al (1992) Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 51:627–631

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B et al (1997) Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 24:1317–1323

    PubMed  CAS  Google Scholar 

  3. Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729–748

    Article  PubMed  Google Scholar 

  4. Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F et al (2005) Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 14:315–320

    Article  PubMed  CAS  Google Scholar 

  5. Antón JM, Castro P, Espinosa G, Marcos M, Gandía M, Merchán R et al (2012) Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. Clin Exp Rheumatol 30:338–344

    PubMed  Google Scholar 

  6. Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E et al (2013) Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med 24:e40–e44

    Article  PubMed  Google Scholar 

  7. Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA et al (2015) Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med 2:e000122

    Article  PubMed  PubMed Central  Google Scholar 

  8. Heijnen T, Wilmer A, Blockmans D, Henckaerts L (2016) Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study. Scand J Rheumatol 45:146–150

    Article  PubMed  CAS  Google Scholar 

  9. Thong BY, Tai DY, Goh SK, Johan A (2001) An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singap 30:254–259

    PubMed  CAS  Google Scholar 

  10. Moreels M, Mélot C, Leeman M (2005) Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 31:591–593

    Article  PubMed  Google Scholar 

  11. Cavallasca JA, del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A et al (2010) Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol 16:400–402

    Article  PubMed  Google Scholar 

  12. Brünnler T, Susewind M, Hoffmann U, Rockmann F, Ehrenstein B, Fleck M (2015) Outcomes and prognostic factors in patients with rheumatologic diseases admitted to the ICU. Intern Med 54:1981–1987

    Article  PubMed  CAS  Google Scholar 

  13. Pène F, Hissem T, Bérezné A, Allanore Y, Geri G, Charpentier J et al (2015) Outcome of patients with systemic sclerosis in the intensive care unit. J Rheumatol 42:1406–1412

    Article  PubMed  Google Scholar 

  14. Shalev T, Haviv Y, Segal E, Ehrenfeld M, Pauzner R, Levy Y et al (2006) Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. Clin Exp Rheumatol 24:380–386

    PubMed  CAS  Google Scholar 

  15. Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26:1851–1855

    Article  PubMed  Google Scholar 

  16. Peng J-M, Du B, Wang Q, Weng L, Hu X-Y, Wu C-Y et al (2016) Dermatomyositis and polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS ONE 11:e0154441

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Hsu C-L, Chen K-Y, Yeh P-S, Hsu Y-L, Chang H-T, Shau W-Y et al (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 9:R177

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ñamendys-Silva S, Baltazar-Torres J, Rivero-Sigarroa E, Fonseca-Lazcano J, Montiel-López L, Domínguez-Cherit G (2009) Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus 18:1252–1258

    Article  PubMed  Google Scholar 

  19. Fatemi A, Shamsaee S, Raeisi A, Sayedbonakdar Z, Smiley A (2017) Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit. Clin Rheumatol 36:2471–2477

    Article  PubMed  Google Scholar 

  20. Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y et al (2003) Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 42:1183–1188

    Article  PubMed  CAS  Google Scholar 

  21. Khan SA, Subla MR, Behl D, Specks U, Afessa B (2007) Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest 131:972–976

    Article  PubMed  Google Scholar 

  22. Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit. Ren Fail 30:890–895

    Article  PubMed  Google Scholar 

  23. Befort P, Corne P, Filleron T, Jung B, Bengler C, Jonquet O et al (2013) Prognosis and ICU outcome of systemic vasculitis. BMC Anesthesiol 13:27

    Article  PubMed  PubMed Central  Google Scholar 

  24. Monti S, Montecucco C, Pieropan S, Mojoli F, Braschi A, Caporali R (2015) Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series. Clin Exp Rheumatol 33:S-126-31

    PubMed  Google Scholar 

  25. Kimmoun A, Baux E, Das V, Terzi N, Talec P, Asfar P et al (2015) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care 20:27

    Article  Google Scholar 

  26. Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau C et al (2015) Outcomes in critically ill patients with systemic rheumatic disease. Chest 148:927–935

    Article  PubMed  Google Scholar 

  27. Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R et al (2016) A population-based study of intensive care unit admissions in rheumatoid arthritis. J Rheumatol 43:26–33

    Article  PubMed  Google Scholar 

  28. Ozbalkan Z, Topeli A, Kiraz S, Ozturk MA, Ertenli I, Calguneri M (2004) The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort study. Clin Exp Rheumatol 22:223–226

    PubMed  CAS  Google Scholar 

  29. Haviv Y, Shovman O, Bragazzi NL, Sharif K, Yavne Y, Shoenfeld Y et al (2017) Patients with vasculitides admitted to the intensive care unit: implications from a single-center retrospective study. J Intensive Care Med. https://doi.org/10.1177/0885066617717223

    PubMed  Article  Google Scholar 

  30. Demiselle J, Auchabie J, Beloncle F, Gatault P, Grangé S, Du Cheyron D et al (2017) Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intensive Care 7:39

    Article  PubMed  PubMed Central  Google Scholar 

  31. Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden PV (2017) Prognosis of patients with rheumatic diseases admitted to intensive care. Anaesth Intensive Care 45:67–72

    PubMed  CAS  Google Scholar 

  32. Faverio P, Pesci A, Esquinas AM (2016) Systemic sclerosis and outcome in intensive care unit: do not close the door, open the right protocol. J Rheumatol 43:676–677

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Rheumatology, Wrightington Hospital, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK

    Mohanned Mustafa, Easwaradhas Gladston Chelliah & Michael Hughes

  2. Department of Rheumatology, Sheffield University Hospitals NHS Foundation Trust, Sheffield, UK

    Michael Hughes

Authors
  1. Mohanned Mustafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Easwaradhas Gladston Chelliah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Hughes.

Ethics declarations

Conflict of interest

No authors have any potential conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mustafa, M., Gladston Chelliah, E. & Hughes, M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatol Int 38, 1163–1168 (2018). https://doi.org/10.1007/s00296-018-4008-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-4008-2

Keywords

  • Rheumatology
  • Systemic rheumatic diseases
  • Intensive care unit
  • Prognosis
  • Outcomes